DC
ARCT icon

Diametric Capital’s Arcturus Therapeutics ARCT Stock Holding History

Diametric Capital’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-20,786
Closed -$383K – 382
2025
Q3 		$383K Sell
20,786
-38,409
-65% -$617K 0.14% 193
2025
Q2 		$770K Buy
59,195
+46,569
+369% +$551K 0.41% 67
2025
Q1 		$134K Buy
+12,626
New +$200K 0.16% 152
2024
Q4 		– Sell
-34,102
Closed -$792K – 318
2024
Q3 		$792K Buy
34,102
+1,337
+4% +$28.6K 0.39% 71
2024
Q2 		$798K Buy
32,765
+19,766
+152% +$599K 0.43% 60
2024
Q1 		$439K Sell
12,999
-13,919
-52% -$493K 0.24% 97
2023
Q4 		$849K Buy
26,918
+788
+3% +$18.7K 0.52% 56
2023
Q3 		$668K Buy
26,130
+4,856
+23% +$150K 0.28% 112
2023
Q2 		$610K Sell
21,274
-10,895
-34% -$297K 0.27% 100
2023
Q1 		$771K Buy
+32,169
New +$577K 0.37% 82
2022
Q3 		– Sell
-22,499
Closed -$354K – 258
2022
Q2 		$354K Buy
+22,499
New +$442K 0.26% 136
2021
Q4 		– Sell
-5,280
Closed -$252K – 159
2021
Q3 		$252K Sell
5,280
-1,137
-18% -$51K 0.2% 108
2021
Q2 		$217K Buy
+6,417
New +$217K 0.16% 111
2020
Q4 		– Sell
-10,248
Closed -$440K – 164
2020
Q3 		$440K Sell
10,248
-1,230
-11% -$61.1K 0.33% 74
2020
Q2 		$536K Sell
11,478
-39,543
-78% -$1.36M 0.41% 72
2020
Q1 		$693K Sell
51,021
-961
-2% -$12.3K 0.84% 47
2019
Q4 		$565K Buy
51,982
+13,521
+35% +$142K 0.41% 79
2019
Q3 		$395K Buy
38,461
+254
+0.7% +$2.75K 0.33% 76
2019
Q2 		$361K Sell
38,207
-16,979
-31% -$125K 0.23% 82
2019
Q1 		$377K Buy
+55,186
New +$282K 0.3% 75

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Diametric Capital's ARCT Position: Q4 2025 in Review

Diametric Capital sold out of Arcturus Therapeutics (ARCT) in Q4 2025, closing a stake of 20,786 shares — an estimated $383K sold.

Diametric Capital first reported a position in ARCT in Q1 2019 and held it in 20 quarters. The position peaked at $849K in Q4 2023. 120 funds tracked by Wall St. Rank hold ARCT as of Q4 2025.

  • Diametric Capital reported no remaining Arcturus Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Diametric Capital sold 20,786 Arcturus Therapeutics shares in Q4 2025, an estimated $383K.
  • Diametric Capital first reported a position in Arcturus Therapeutics in Q1 2019 and held it in 20 quarters.
  • Diametric Capital's Arcturus Therapeutics position peaked at $849K in Q4 2023.
  • 120 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q4 2025.

Based on Diametric Capital's 13F filing for Q4 2025, filed 13 Feb 2026.